← All companies

ADRX

ADARx Pharmaceuticals, Inc.

ADRX Pharmaceutical Preparations EDGAR ↗

$20.64

+0.55 +2.71%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$18.50 – $23.21

Recent SEC filings

37 most recent

Annual, quarterly & current reports

8-K Unregistered sale of equity; Amended charter or bylaws; Other events Sep 28, 2026

Other filings

S-8 Sep 28, 2026

424B4 Sep 28, 2026

EFFECT Sep 24, 2026

S-1MEF Sep 24, 2026

CERT Sep 24, 2026

8-A12B Sep 22, 2026

S-1/A Sep 21, 2026

S-1/A Sep 14, 2026

S-1 Sep 4, 2026

DRS/A Jul 31, 2026

DRS Jun 22, 2026

D Item 06b Aug 10, 2023

D Item 06b Jan 26, 2023

D Item 06b Aug 17, 2021

D Item 06b May 24, 2021

D Item 06b Nov 17, 2020

D Item 06b Aug 7, 2020

D Item 06b Feb 6, 2020